Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 19, 2026 · Filed May 22, 2026
A major shareholder of Inmed Pharmaceuticals paid $312K out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$312,080
Shares × reported transaction price
$100K–$500K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $8.00 on May 19, 2026, 160% above its 52-week low and 59% below its high, after a 135% rise over the previous 30 trading days
52-week range $3.08 (Mar 30, 2026) to $19.35 (Jun 24, 2025), 30% of the way up, from 251 adjusted closes. 30 trading days earlier: $3.40 on Apr 7, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The largest open-market purchase by any INM insider in filings since 2021. The first open-market purchase by any INM insider since Feb 2024. ADAR1 Capital Management's first open-market purchase of INM in filings since 2021
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −8.7% | +1.4% | −10.2% |
| 30 days | −12.8% | −0.2% | −12.6% |
| 90 days | −8.1% | +2.3% | −10.4% |
Past results only. Not a forecast.
Insider buying
Traded May 21 · filed 21 days later
A major shareholder of Inmed Pharmaceuticals paid $52K out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
Insider buying
Traded May 21 · filed 21 days later
A major shareholder of Inmed Pharmaceuticals paid $5.3K out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
Insider buying
Traded May 29 · filed 13 days later
A major shareholder of Inmed Pharmaceuticals paid $25K out of pocket for Inmed Pharmaceuticals shares. 1 other person at Inmed Pharmaceuticals bought some too, in the same month.
ADAR1 Capital Management, LLC, 10% owner's past purchases, 90 days after disclosure: 9 buys, median +2.3 pts vs S&P 500, beat it 6 of 9 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
